Biocept, Inc. is a molecular oncology diagnostics company specializing in Circulating Tumor Cells (CTCs) and biomarker analysis, headquartered in San Diego, California.

Biocept's mission is to improve outcomes for cancer patients by advancing oncology diagnostics.

Biocept utilizes patented and innovative technologies to deliver clinically relevant oncology diagnostics to physicians by providing advanced prognostic and predictive assessments for guiding the course of treating patients. Additionally, Biocept offers services to other laboratory testing providers, academic institutions, research organizations, biopharmaceutical companies, and clinical trial support.

Find a broker to begin trading BIOC now

Company Name Biocept
Market/Symbol NASDAQ: BIOC
Recent Price
Market Cap $12.31M
Avg. Daily Vol. (3m) 2,282,265
Price/Book N/A
Price/Cash Flow N/A
As of May. 25, 2018
*Source: QuoteMedia

Begin trading BIOC

 Find Broker



Recent Company Videos

Biocept (NASDAQCM: BIOC) - RedChip Global Online CEO Conference

Apr. 29, 2014

Presentation and Investor Q&A with Mike Nall, CEO of Biocept (NASDAQCM: BIOC), a molecular oncology diagnostics company specializing in Circulating ...

Biocept Latest News

Ask the CEO

Meet The Board of Directors

David F. Hale

Chairman of the Board

Michael W. Nall

President & Chief Executive Officer

M. Faye Wilson

Lead Director

Marsha A. Chandler

Bruce E Gerhardt

Bruce A. Huebner

Ed Neff

Ivor Royston

Meet The Management Team

Michael W. Nall

President & Chief Executive Officer

Lyle Arnold

Senior Vice President, Research & Development & Chief Scientific Officer

Bill Kachioff

Senior Vice President, Finance & Chief Financial Officer

Farideh Z. Bischoff

Vice President, Translational Research and Clinical Development

Raaj Trivedi

Vice President, Commercial Operations

Philip D. Cotter

Director of Clinical Laboratories

Receive BIOC Email Alerts

*By entering your information you agree to our privacy policy.

"I work with many of the companies that would be RedChip companies. And we certainly ascribe to the same view that the RedChip Companies do, which is Discovering Tomorrow's Blue Chips Today."

  • Bob McCooey, Senior Vice President, NASDAQ Stock Market